ATP13A2 and Parkinson disease: In addition, the PARK7 p.A104S and ATP13A2 p.R172H, p.S277C, p.P358L, p.R924H and p.R980H heterozygous variants had higher CADD and REVEL scores but were not reported to be pathogenic for PD in ClinVar or MDSgene.